Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

Daskalopoulos Georgios; Karkanaki Artemis; Piouka Athanasia; Prapas Nikolaos; Panidis Dimitrios; Gkeleris Paraschos; Athyros Vasilios G.

首页> 外文期刊>Current vascular pharmacology >Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

【24h】

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

机译：多囊卵巢综合症的所有表型均未体现出过多的代谢和心血管风险：对诊断和治疗的意义

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim: To assess the potential differences in the metabolic and cardiovascular disease (CVD) risk between the distinct phenotypes of the Polycystic Ovary Syndrome (PCOS) according to the Rotterdam definition regardless of body mass index (BMI).

机译：目的：根据鹿特丹的定义，评估无论体重指数（BMI）如何，多囊卵巢综合症（PCOS）的不同表型之间在代谢和心血管疾病（CVD）风险方面的潜在差异。

著录项

来源
《Current vascular pharmacology 》 |2015年第6期| 共13页
作者
Daskalopoulos Georgios; Karkanaki Artemis; Piouka Athanasia; Prapas Nikolaos; Panidis Dimitrios; Gkeleris Paraschos; Athyros Vasilios G.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学 ;
关键词
Polycystic ovary syndrome; cardiovascular risk; high sensitivity C reactive protein; lipoprotein-associated phospholipase A(2); treatment; statins; insulin sensitizers; risk score engines;

机译：多囊卵巢综合征;心血管疾病风险;高敏C反应蛋白;脂蛋白相关磷脂酶A（2）;治疗;他汀类药物;胰岛素增敏剂;风险评分引擎;

相似文献

外文文献
中文文献
专利

1. Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment [J] . Daskalopoulos Georgios, Karkanaki Artemis, Piouka Athanasia, Current vascular pharmacology . 2015 ,第6期

机译：多囊卵巢综合症的所有表型均未体现出过多的代谢和心血管风险：对诊断和治疗的意义
2. Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis [J] . Christ J. P., Gunning M. N., Fauser B. C. J. M. Reproductive biomedicine online . 2017 ,第4期

机译：2014年雄激素过量和多囊卵巢综合征社会对多囊卵巢综合征诊断多囊卵巢形态的影响
3. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome [J] . Charikleia D Christakou‌ Evanthia Diamanti-Kandarakis‌† Women's Health . 2008 ,第6期

机译：多囊卵巢综合征女性中雄激素过多对代谢异常和心血管风险的作用
4. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease:review of the evidence [C] . Evelyn O. Talbott, Jeanne V. Zborowski, Monique Y. Boudreaux World Congress on Fertility and Sterility . 2004

机译：具有多囊卵巢综合征的妇女是否具有增加的心血管疾病风险：审查证据
5. Validation of the obese Ossabaw miniature pig as a model of the obese polycystic ovary syndrome phenotype with concomitant metabolic syndrome: Exploration of polycystic ovary syndrome pathophysiology using in vivo and in vitro models [D] . Newell-Fugate, Anne Elizabeth 2012

机译：肥胖的Ossabaw小型猪作为肥胖多囊卵巢综合征表型伴有代谢综合征的模型的验证：利用体内和体外模型探索多囊卵巢综合征的病理生理学
6. Drospirenone/Ethinyl Estradiol Versus Rosiglitazone Treatment in Overweight Adolescents with Polycystic Ovary Syndrome: Comparison of Metabolic Hormonal and Cardiovascular Risk Factors [O] . Hala Tfayli, Julia Warren Ulnach, SoJung Lee, -1

机译：屈螺酮/乙炔雌二醇与罗格列酮治疗超重多囊卵巢综合征青少年：代谢激素和心血管危险因素的比较
7. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society [O] . Wild, R., Carmina, E., Diamanti-Kandarakis, E., 2010

机译：多囊卵巢综合征患者的心血管风险评估和心血管疾病预防：雄激素过量和多囊卵巢综合征（aE-pCOs）协会的共识声明

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

摘要

著录项

相似文献

相关主题

期刊订阅